Investor insights
Sectors invested in
Health Care1
Biopharma1
Pharmaceutical1
Medical1
Biotechnology1
Funding rounds participated in
$147M sweet spot round size
Most of their 1 investments are in rounds between $147M and $147M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
additional 20 countries on registration.
TDDS(Transdermal Drug Delivery System)
Affil
Exporting to more than 20 countries at now
Pharmaceutical
Pharmaceutical Products(API & Finished prodcuts)
Affiliated company in German and China.
Health Care
World firstly approved oral paclitaxel - LIPORAXEL Soln.
DDS(Drug Delivery System)
DHLASED(DaeHwa Lipid-bAsed Self-Emulsifying Drug delivery)
Date founded
1984
Investments made
上
上海海和药物研究开发有限公司 raised $147M on February 11, 2019
Investors: 博远资本, 盈科创新资产管理有限公司, 华盖资本有限责任公司, CSPC Pharmaceutical Group Ltd, Hillhouse Capital Management, Atlas Capital LLC and DAEHWA PHARMACEUTICAL CO., LTD.